JP2023517636A5 - - Google Patents

Info

Publication number
JP2023517636A5
JP2023517636A5 JP2022554671A JP2022554671A JP2023517636A5 JP 2023517636 A5 JP2023517636 A5 JP 2023517636A5 JP 2022554671 A JP2022554671 A JP 2022554671A JP 2022554671 A JP2022554671 A JP 2022554671A JP 2023517636 A5 JP2023517636 A5 JP 2023517636A5
Authority
JP
Japan
Prior art keywords
composition
use according
subject
disease
clinical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022554671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023517636A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/056191 external-priority patent/WO2021180850A1/en
Publication of JP2023517636A publication Critical patent/JP2023517636A/ja
Publication of JP2023517636A5 publication Critical patent/JP2023517636A5/ja
Pending legal-status Critical Current

Links

JP2022554671A 2020-03-11 2021-03-11 炎症性腸疾患を治療するための方法ｉ Pending JP2023517636A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020900742A AU2020900742A0 (en) 2020-03-11 Method for treating inflammatory bowel disease I
AU2020900742 2020-03-11
PCT/EP2021/056191 WO2021180850A1 (en) 2020-03-11 2021-03-11 Method for treating inflammatory bowel disease i

Publications (2)

Publication Number Publication Date
JP2023517636A JP2023517636A (ja) 2023-04-26
JP2023517636A5 true JP2023517636A5 (enExample) 2024-03-13

Family

ID=74884937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554671A Pending JP2023517636A (ja) 2020-03-11 2021-03-11 炎症性腸疾患を治療するための方法ｉ

Country Status (9)

Country Link
US (1) US20230172991A1 (enExample)
EP (1) EP4117691A1 (enExample)
JP (1) JP2023517636A (enExample)
KR (1) KR20220152239A (enExample)
CN (1) CN115361957A (enExample)
AU (1) AU2021234104A1 (enExample)
BR (1) BR112022017560A2 (enExample)
CA (1) CA3170915A1 (enExample)
WO (1) WO2021180850A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087868A1 (en) 2010-10-08 2012-04-12 Gabriele Todd Nanoparticle-loaded cells
SG11202004680UA (en) 2017-11-22 2020-06-29 Mesoblast Int Sarl Cellular compositions and methods of treatment i
WO2021180851A1 (en) * 2020-03-11 2021-09-16 Mesoblast International Sàrl Method for treating inflammatory bowel disease ii

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
US8465733B2 (en) * 2007-11-02 2013-06-18 Jcr Pharmaceuticals Co., Ltd. Pharmaceutical composition containing human mesenchymal stem cell
CN104873542A (zh) * 2015-05-21 2015-09-02 北京青藤谷禧干细胞科技研究院有限公司 一种脐带间充质干细胞注射液及其制备方法和应用
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
WO2018002930A1 (en) * 2016-06-30 2018-01-04 Stem Cell Medicine Ltd. Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
WO2018182612A1 (en) * 2017-03-30 2018-10-04 Progenity Inc. Methods and ingestible devices for the regio-specific release of stem cells at the site of gastrointestinal tract disease
WO2021180851A1 (en) * 2020-03-11 2021-09-16 Mesoblast International Sàrl Method for treating inflammatory bowel disease ii

Similar Documents

Publication Publication Date Title
JP2023517641A5 (enExample)
Kochhar et al. Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension
JP2023517636A5 (enExample)
Toubia et al. Portal hypertension and variceal hemorrhage
Singh et al. Perianal Crohn's disease
CN102973554B (zh) 土木香内酯在制备防治溃疡性结肠炎的药物或食品中的应用
Tepes et al. Stable gastric pentadecapeptide BPC 157 therapy for primary abdominal compartment syndrome in rats
JP2019523274A (ja) 生物活性治療を実施するための生体接着性プラットフォーム
WO2022134306A1 (zh) 3-羟基丁酸或其衍生物或可产生该物质的细菌组合物在治疗放射性肠损伤上的应用
Macarak et al. Trametinib prevents mesothelial-mesenchymal transition and ameliorates abdominal adhesion formation
CN118717990A (zh) Smyd2在抑制腹主动脉瘤生长中的应用
Hvas et al. Diagnosis and treatment of fistulising Crohn’s disease
Lee et al. Primary Aortoenteric Fistula to the Sigmoid Colon in Association with Intraabdominal Abscess
CN103040805A (zh) 辛夷脂素的医药用途
Rubio et al. “Nonspecific” erosions and ulcers of the colonic mucosa
RU2364405C1 (ru) Способ лечения воспалительных заболеваний кишечника
Penner et al. Resolution of multiple severe nonsteroidal anti‐inflammatory drug‐induced colonic strictures with prednisone therapy: a case report and review of the literature
CN102302442B (zh) 一种大蒜素阴道栓剂及其制备方法
CN118873490B (zh) 一种预凝胶溶液及其制备方法、成胶验证方法与应用
Mateshuk-Vatseba et al. Morphological features of the wall of common bile duct under the conditions of experimental opioid exposure
Detry et al. Subacute ischaemic proctitis: A rare condition requiring extensive rectal surgery
Brînzan et al. OTSC FOR PRIMARY HEMOSTASIS IN SEVERE PEPTIC UPPER GI BLEEDING-IS IT A SOLUTION?
CN119950520A (zh) 7-酮脱氧胆酸在治疗肠黏膜缺损相关疾病中的应用
Ghosh et al. A review on pharmacological and therapeutic Insight of ozanimod for colon disease in nanostructure
Bari et al. ROLE OF PRE-OPREATIVE BILIARY DRAINAGE IN BENIGN SURGICAL OBSTRUCTIVE JAUNDICE.